1.52p+0.06 (+3.77%)21 May 2024, 17:07
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo

Hemogenyx Pharmaceuticals PLC Market & Company News

25.04.2024 12:19GAL, HEMO, AERIEARNINGS: LSL starts 2024 "strongly"; Focusrite maintains payoutAlliance
25.04.2024 07:00HEMOFinal ResultsRNS
28.03.2024 07:00HEMOTotal Voting RightsRNS
29.02.2024 14:04HEMOHemogenyx Pharmaceuticals raises money for leukaemia treatmentAlliance
29.02.2024 07:00HEMOPlacing to Raise US$4.2 millionRNS
16.02.2024 11:27HEMOHemogenyx shares rise on potential for CBR to treat brain diseasesAlliance
16.02.2024 07:00HEMOCBR Brain DeliveryRNS
14.02.2024 10:14HEMOHemogenyx says CBR can be used intranasally to treat viral infectionsAlliance
14.02.2024 07:00HEMOCBR Intranasal DeliveryRNS
09.02.2024 10:00HEMOIN BRIEF: Hemogenyx shares surge as FDA lifts Hemo-Car-T trial holdAlliance
02.02.2024 10:44HEMOIN BRIEF: Hemogenyx hails US patent application progressAlliance
16.01.2024 11:13HEMOHemogenyx Pharmaceuticals sends complete response on HEMO-CAR-T to FDAAlliance
16.01.2024 07:00HEMOSubmission of Complete Response to Clinical HoldRNS
08.01.2024 10:56HEMOHemogenyx Pharmaceuticals completes process qualification runAlliance
08.01.2024 07:00HEMOHEMO-CAR-T Process Qualification Run CompletedRNS
28.11.2023 16:53HEMO, UPL, FDPTRADING UPDATES: Upland Resources completes technical study at SarawakAlliance
28.11.2023 12:19HEMOPlacing to Raise £534,375RNS
27.11.2023 10:52HEMOHemogenyx shares up as says CBR platform a potential cancer treatmentAlliance
27.11.2023 07:00HEMOCBR Expanded to Treatment of CancerRNS
15.11.2023 15:43HEMO Hemogenyx Pharmaceuticals completes lentivirus re-manufactureAlliance
15.11.2023 07:00HEMOLentivirus Re-manufacturing CompletedRNS
31.10.2023 07:00HEMOTotal Voting RightsRNS
28.09.2023 14:24DAR, NSCI, MET1EARNINGS: Dar Global profit multiplies, Hemogenyx loss widensAlliance
28.09.2023 12:28HEMOHalf-year ReportRNS
18.09.2023 14:37HEMO, CRTM, BSFATRADING UPDATES: Avingtrans buys Adaptix, TPXimpact sells QuestersAlliance
18.09.2023 07:00HEMOStrategic Investment from Prevail Partners, LLCRNS
14.09.2023 14:31HEMOHemogenyx Pharma says US FDA accepts Hemo-Car-T clinical hold lift planAlliance
14.09.2023 07:00HEMOClinical Hold Lift Plan is accepted by FDARNS
08.09.2023 19:43HEMOIN BRIEF: Hemogenyx Pharmaceuticals says patent number publishedAlliance
08.09.2023 17:11HEMOCBR Patent Application UpdateReach
10.07.2023 10:27HEMOHemogenyx says Hemo-Car-T treatment placed on clinical hold by US FDAAlliance
10.07.2023 07:00HEMOFull FDA Review for HEMO-CAR-T INDRNS
30.06.2023 16:07HEMOResult of Annual General MeetingRNS
23.06.2023 15:51CHSS, URAH, STGUK shareholder meetings calendar - next 7 daysAlliance
02.06.2023 14:01HEMOPosting of Annual Report & Notice of AGMRNS
02.06.2023 13:08HEMOIN BRIEF: Hemogenyx announces clinical hold for Hemo-Car-T treatmentAlliance
02.06.2023 11:24HEMOClinical Hold on IND for HEMO-CAR-TRNS
09.05.2023 15:16HEMOIN BRIEF: Hemogenyx submits FDA application for Hemo-Car-T treatmentAlliance
09.05.2023 07:00HEMOSubmission of IND for HEMO-CAR-TRNS
28.04.2023 15:35HEMO, LSAA, CHFEARNINGS SUMMARY: DP Aircraft profit swing, Chesterfield loss widens Alliance
28.04.2023 10:05HEMOEquity Incentive Pool Increase and Option GrantRNS
28.04.2023 07:00HEMOFinal Results for the Year Ended 31 December 2022RNS
23.03.2023 20:32RKH, HEMO, FPPTRADING UPDATES: Fragrant Prosperity to buy Hi 55, Oscillate talks endAlliance
23.03.2023 13:32HEMOHEMO-CAR-T Analytical Release Tests CompletedReach
28.02.2023 07:00HEMOTotal Voting RightsRNS
07.02.2023 14:30HEMOAdmission of Shares to Official ListRNS
26.01.2023 10:45HEMOHemogenyx raises GBP4 million in share placing for Hemo-CAR-T productAlliance
26.01.2023 09:05HEMOSecond Price Monitoring ExtnRNS
26.01.2023 09:00HEMOPrice Monitoring ExtensionRNS
26.01.2023 07:00HEMOPlacing to Raise £4,056,250RNS
23.01.2023 16:59HEMOIN BRIEF: Hemogenyx completes process run for HEMO-CAR-T manufactureAlliance
23.01.2023 07:00HEMOHEMO-CAR-T 3rd Process Qualification Run CompletedReach
16.01.2023 16:40HEMOSecond Price Monitoring ExtnRNS
16.01.2023 16:35HEMOPrice Monitoring ExtensionRNS
13.01.2023 11:05HEMOSecond Price Monitoring ExtnRNS
13.01.2023 11:00HEMOPrice Monitoring ExtensionRNS
12.01.2023 16:40HEMOSecond Price Monitoring ExtnRNS
12.01.2023 16:35HEMOPrice Monitoring ExtensionRNS
12.01.2023 14:05HEMOSecond Price Monitoring ExtnRNS
12.01.2023 14:00HEMOPrice Monitoring ExtensionRNS
10.01.2023 16:35HEMOPrice Monitoring ExtensionRNS
09.01.2023 10:21HEMOHemogenyx shares up on single target protein virus treatment findingAlliance
09.01.2023 09:05HEMOSecond Price Monitoring ExtnRNS
09.01.2023 09:00HEMOPrice Monitoring ExtensionRNS
09.01.2023 07:00HEMOSingle CBR Can Treat Multiple VirusesReach
05.01.2023 16:40HEMOSecond Price Monitoring ExtnRNS
05.01.2023 16:35HEMOPrice Monitoring ExtensionRNS
05.01.2023 11:05HEMOSecond Price Monitoring ExtnRNS
05.01.2023 11:00HEMOPrice Monitoring ExtensionRNS
04.01.2023 11:12HEMOIN BRIEF: Hemogenyx Pharma second process qualification run successfulAlliance
04.01.2023 10:36HEMO, HEIQSMALL-CAP WINNERS & LOSERS: HeiQ drops on expectation of lower salesAlliance
04.01.2023 07:00HEMOHEMO-CAR-T Process Qualification Run CompletedReach
12.12.2022 07:00HEMOHEMO-CAR-T First PQ Run CompletedReach
18.11.2022 16:21HEMOHemogenyx makes final development run of HEMO-CAR-T cell manufactureAlliance
18.11.2022 15:19HEMOHEMO-CAR-T Process Development Runs CompletedReach
Showing 1 to 75 of 196